Delivery Order SPE2DB24D8002-SPE2DB25FJMMP
Award Date
10/9/24
Potential Completion Date
10/10/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DX15D8002|SPE2DX24F2TG4 was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,506.20 firm fixed-price delivery order is for the pharmaceutical product VEMLIDY 25 MG TABLET, with a performance period ending on October 16, 2023. Dakota Drug, Inc. also holds a $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,978.01 firm fixed-price contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of November 5, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $6,195.56 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Under this contract, Dakota Drug will provide 25 mg tablets of VEMLIDY, a medication used to treat hepatitis B virus infection, to Minot, North Dakota in quantities of 30 tablets per unit. No set-aside was designated for this...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,120.76, is for the delivery of Vemlidy 25 mg Tablet with an ultimate completion date of April 16, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, which is part of...
This federal contract award SPE2DX15D8002|SPE2DX24F2WS3, valued at $1,651.67, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of DAPAGLIFLOZIN 5 MG TABLET 30S, a pharmaceutical product, to support the DLA Troop Support Medical division. This award is not associated with a set-aside program. Additionally, Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,900.47, is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract has a ceiling value of $11,519.50 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside contract. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The company specializes in providing...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract falls under the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Through this single-award IDC, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,468.17 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, identified as SPE2DB24D8003|SPE2DB25FJTZF, has an ultimate completion date of March 14, 2025. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,101.32 firm fixed price contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that enables the company to provide...